Clinical Trial

Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated July 12, 2025 completion). Its status may not reflect the trial's current state.
Summary
Interstitial lung diseases (ILD) are a group of chronic respiratory diseases that cause significant mortality and morbidity worldwide. Although there are studies in the literature comparing different lung disease groups with healthy individuals, it has been determined that there is no study comparing the exercise capacity, muscle oxygenation, physical activity level, respiratory functions, respiratory and peripheral muscle strength, inspiratory muscle endurance, quality of life and sleep quality of individuals diagnosed with ILD with healthy individuals.
Trial Details
NCT Number NCT06948942
Lead Sponsor Gazi University
Conditions Interstitial Lung Diseases (ILD), Healthy Individuals, Exercise Capacity, Muscle Oxygenation, Physical Activity Level
Enrollment 40 participants
Start Date 2024-12-12
Primary Completion 2025-07-12 (estimated)
Study Completion 2025-09-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-29